TOLREMO therapeutics is a company that provides Drug resistance, Cancer therapy, Small molecule and more. TOLREMO therapeutics is headquartered in Switzerland Zurich. TOLREMO therapeutics was founded in 2017. and was founded by Emmanuel Savioz, Isaac Kobrin, Karl-Heinz Altmann, Stefanie Flückiger-Mangual, Wilhelm Krek. TOLREMO therapeutics has a total of 20 patents
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of TOLREMO therapeutics
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by TOLREMO therapeutics
Sign up to view the full data
Free Trial Now
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for TOLREMO therapeutics
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for TOLREMO therapeutics
Sign up to view the full data
Free Trial Now
Download
Top Related Companies
Sign up to view the full data
Free Trial Now
TOLREMO therapeutics Frequently Asked Questions
What is TOLREMO therapeutics's industry?
TOLREMO therapeutics is in the industry of:Pharmaceutical and Medicine ManufacturingPharmacies and Drug Stores Research and Development in the Physical, Engineering, and Life Sciences
What technical fields has TOLREMO therapeutics researched?
TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.The company's molecules specifically...